W.E. Vinson

Effect of low dose of FSH given at the beginning of the estrous cycle and subsequent superovulatory response in Holstein cows

A total of 47 superovulations were conducted on forty non-lactating cows to evaluate two different schemes using follicle stimulating hormone (FSH) for superovulating cattle. Cows randomly assigned to treatment A (26 collections) were superovulated beginning on days 9 to 13 of the estrous cycle by giving FSH at decreasing doses of 6, 6, 5, 5, 3, 3, and 2, 2 mg for 4 consecutive days at 12-h intervals while those in treatment B (21 collections) also received 2.5 mg of FSH on days 3 and 4 of the estrous cycle. Animals in both treatments were each given 12.5 mg of prostaglandin F2alpha (PGF2alpha) at 60 and 72 h after the initiation of superovulatory treatment. Cows were artificially inseminated at 0, 12, and 24 h after the onset of estrus. Embryos were recovered nonsurgically on d 6 and morphologically evaluated. Ovaries of the cows were palpated at the end of flushings to assess the number of corpora lutea (CL). The mean interval from PGF2alpha to the onset of estrus was not different (P>0.05) for treatments A (56.6 h) and B (50.0 h). Also, mean duration of standing estrus was not different for either treatment (13.4 h vs 12.8 h). The mean number of CL palpated (7.3 vs 12.9) and ova recovered (5.5 vs 14.2) were significantly greater (P<0.05) for treatment B. The mean number of excellent and good embryos recovered was lower for treatment A animals, but not significant (P>0.05). Therefore, low doses of FSH given at the beginning of the cycle increased ovulation rate and embryo recovery in non-lactating cows.

Observations on in vitro development of bovine morulae in Ham's F-10 and Dulbecco's phosphate buffered saline supplemented with normal steer serum

This study was conducted to compare in vitro development of bovine morulae in Hams F-10 and Dulbeccos phosphate buffered saline (D-PBS) media supplemented with 10% (v/v) normal steer serum. Fifty-three excellent and good embryos were obtained by superovulating 15 non-lactating Holstein cows. Embryos were placed randomly in culture with Hams F-10 or D-PBS media and development was recorded at 12-h intervals for the duration of culture. All embryos reached early blastocyst, blastocyst and expanded blastocyst stage. Nineteen of 27 embryos (70.1%) cultured in Hams F-10 developed to hatched blastocyst stage in contrast to three out of 26 in D-PBS (11.5%). The mean developmental scores at 24, 48, 72, 96 and 120 h of culture were significantly (P<0.001) higher for embryos cultured in Hams F-10. Also, the mean times to reach early blastocyst (25.84 +/- 6.65 vs 46.67 +/- 9.99 h), blastocyst (44.57 +/- 11.45 vs 61.89 +/- 16.62 h) and expanded blastocyst stage (65.00 +/- 13.20 vs 73.41 +/- 15.80 h) were significantly (P<0.001) shorter for embryos cultured in Hams F-10. No difference was observed in the mean time to reach hatching (90.00 +/- 10.85 vs 84.00 +/- 16.97 h) and hatched blastocyst stage (97.26 +/- 18.71 vs 96.00 +/- 0.00 h). The results obtained support the concept that Hams F-10 and normal steer serum provide for optimal bovine embryo development and suggest that 10% normal steer serum could be used as a protein supplement with D-PBS for short term storage and culture of bovine embryos.

In vitro development of bovine morulae in bovine serum albumin, normal steer serum and uterine flushings

One hundred fifty-three excellent and good bovine morulae were cultured in Hams F-10, supplemented with 10 % steer serum, bovine serum albumin, or uterine flushings (64 mg protein/ml) to compare embryo development. Embryos were observed every 12 h in culture. Treatment differences were evaluated by assigning a numerical value of 0 to 4 to each embryo representing the stage of development reached in vitro. The final morphological developmental score of the embryos was comparable for steer serum (2.66) and bovine serum albumin (2.50), but it differed significantly for uterine flushings obtained from ovariectomized, steroid-supplemented cows (< 0.1) or heat-treated uterine flushings (0.07). Since albumin alone was able to support development, it suggests that the albumin component of steer serum may be responsible for the observed development. Uterine fluids were unable to support growth of embryos, suggesting that incompatibility may be due to asynchrony between the early bovine embryo and uterine constituents, or a concentration of uterine components may exacerbate actions of inhibitory substances.

Influence of uterine flushings from superovulated cows on in vitro bovine morulae development.

To evaluate early embryo development, 248 good to excellent bovine morulae were cultured in Hams F-10 medium, supplemented with 10% steer serum, uterine flushings from Days 6, 10 or 15 following estrus (0.01, 0.1, 1.0 and 10% protein; 64 mg protein/ml), and 1.0% uterine flushings and 10% steer serum. Final development scores for embryos in steer serum were significantly higher (range across experiments was: 4.06 to 4.37) than for embryos cultured in uterine flushings alone (-0.23 to 0.52). Treatment means were not different (P >0.05) when 10% steer serum was added to 1.0% uterine flushings. A higher percentage of embryos in 10% steer serum (92%) than in 10% steer serum plus 1.0% uterine flushing from Day 6 (33%), Day 10 (45%) and Day 15 (50%) developed to hatched blastocysts. Embryos cultured in 1.0% Day 6 uterine flushings plus 10% steer serum required more time to attain the early blastocyst and blastocyst stages, while embryos in 1.0% Day 15 uterine flushings and 10% steer serum developed at the same rate as controls to the expanded blastocyst stage, but hatched sooner (72.8 vs 96.5 h). These results suggest substance(s) in uterine secretions can have inhibitory and stimulatory influences on early bovine embryo development.

Effect of gestational mastectomy on postpartum gonadotropin releasing hormone and thyrotropin releasing hormone-induced luteinizing hormone and prolactin response in first lactation Holstein cattle.

First lactation Holstein cows were divided into two treatment groups to evaluate thyrotropin releasing hormone (TRH, 0.25 μg/kg body weight) and gonadotropin releasing hormone (GnRH; 200 μg) induced secretion of prolactin (PRL) and luteinizing hormone (LH) on days 7 and 16 postpartum. Disregarding treatment, LH response was greater (p <0.01) on day 16 than day 7 postpartum (7.5 ± 0.3 ng/ml on day 7 vs 10.2 ± 0.3 ng/ml serum on day 16). Mastectomized cattle had similar time for initiation of LH increase, but peak concentrations were achieved later. Peak PRL concentrations were reached 12 to 15 min after injection and returned to baseline within 2.5 h in both groups. However, intact cows had higher (p <0.01) mean serum PRL than the mastectomized cows for 1 h following injection. Peak PRL concentration was 83.3±17.6 ng/ml for mastectomized cows vs 128.0 ± 24.7 ng/ml for intact cows. It appears that udder removal allows for greater pituitary responsiveness to GnRH but diminishes PRL response to TRH suggesting the mammary gland differentially affects pituitary secretion of LH and PRL.

Effect of endothelial cell growth supplement and fibroblastic growth factor on early mouse embryo development in vitro

This study was conducted to examine the effect of endothelial cell growth supplement (ECGS) and fibroblastic growth factor (FGF) on early mammalian embryo development in vitro. Two hundred mouse blastocysts were placed randomly in culture wells containing one of five treatments: 1) Hams F-10, 2) Hams F-10 + 10 mug ECGS, 3) Hams F-10 + 10 ng ECGS, 4) Hams F-10 + 100 ng FGF and 5) Hams F-10 + 10 ng FGF. In all cases, media were supplemented with 10% (v/v) normal steer serum. Embryos were cultured at 37 C with an atmosphere of 5% O(2), 5% CO(2) and 90% N and development was recorded at 12 h intervals for the duration of culture. The percentage of embryos that developed to expanded blastocyst (94.8), hatching blastocyst (74.4) and hatched blastocyst (71.8) in Hams F-10 media were not different from embryos cultured in all other treatments except Hams F-10 + 10 mug ECGS. A decrease in the percentage of embryos reaching expanded blastocyst (44.7), hatching blastocyst (23.7) and hatched blastocyst (18.4) was observed in Hams F-10 + 10 mug ECGS. Also, a significant (P<0.01) decrease in development scores at 24, 48 and 72 h was observed for embryos cultured in Hams F-10 + 10 mug ECGS. No difference was observed in the mean time to reach different developmental stages among treatments. The data suggest that ECGS and FGF at the doses tested have no beneficial effect on early mouse embryo development in vitro and 10 mug of ECGS has inhibitory effect.